Showing 1491-1500 of 1716 results for "".
Selecting the Optimal JAK Inhibitor for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/selecting-the-optimal-jak-inhibitor-for-alopecia-areata/67265/Since 2022, the US Food and Drug Administration (FDA) has approved three oral JAK inhibitors: baricitinib, ritlecitinib, and deuruxolitinib.Staphylococcus aureus Accessory Gene Regulator Quorum-sensing System Inhibits Keratinocyte Lipid Enzymes and Delays Wound Repair
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/staphylococcus-aureus-accessory-gene-regulator-quorum-sensing-system-inhibits-keratinocyte-lipid-enzymes-and-delays-wound-repair/67354/Therapies aimed at inhibiting agr quorum sensing could be a novel strategy to improve healing outcomes.Advancing the Science and Care of Pigmentary Disorders
https://practicaldermatology.com/topics/pigmentary-disorders/advancing-the-science-and-care-of-pigmentary-disorders/67251/These articles reflect the growing sophistication of our understanding of pathogenesis, advances in diagnostic and assessment tools, and the expanding therapeutic landscape that is reshaping patient care.Mohs Micrographic Surgery Access and Distribution Lacking in Louisiana
https://practicaldermatology.com/topics/skin-cancer-photoprotection/mohs-micrographic-surgery-access-and-distribution-lacking-in-louisiana/67058/Precision Medicine for AD
https://practicaldermatology.com/columns/atopic-dermatitis-essentials/precision-medicine-for-ad/54826/A Q & A with Derek MaetzoldThe Hidradenitis Suppurativa Therapeutic Pipeline
https://practicaldermatology.com/topics/rare-disease/the-hidradenitis-suppurativa-therapeutic-pipeline/54824/Though treatment options are currently limited, the pipeline for HS therapeutics is active with numerous medications in development.A Busy Time in the Field
https://practicaldermatology.com/issues/januaryfebruary-2026/a-busy-time-in-the-field/54452/Can Prescription Hyperhidrosis Treatments Help Mitigate Symptoms?
https://practicaldermatology.com/topics/rare-disease/can-prescription-hyperhidrosis-treatments-help-mitigate-symptoms/39997/A Guide to Building Lifelong Patient Loyalty
https://practicaldermatology.com/issues/october-2025/a-guide-to-building-lifelong-patient-loyalty/39758/Interest in medical aesthetic treatments continues to grow and signs indicate that demand will remain strong. Today’s patients are more informed and educated than ever and are seeking personalized, high-quality experiences.The ESOP Model: An Alternative to PE for Dermatology Practices
https://practicaldermatology.com/issues/september-2025/the-esop-model-an-alternative-to-pe-for-dermatology-practices/37637/Not all practice models are as simple as private practice vs private equity. At Ada West Dermatology in Boise, Idaho, we’ve adopted a somewhat uncommon business model called an employee stock ownership plan (ESOP) and it’s worked very well for us.